Biomason Overview
- Founded
- 2012
- Status
- Private
- Employees
- 76
- Latest Deal Type
- Later Stage VC
- (Upcoming)
- Investors
- 8
Biomason General Information
Description
Developer of a building materials technology intended to produce biological cement-based building materials alternatives. The company's bio cement production combines natural microorganisms and chemical processes to develop masonry materials at room temperature, which helps replace traditional clay and concrete, and the high energy consumption associated with standard manufacturing them, enabling builders to acquire alternative building materials that are produced carbon-free.
Contact Information
Website
www.biomason.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Building Products
Other Industries
Other Materials
Primary Office
- Post Office Box 110345
- Research Triangle Park
- Durham, NC 27709
- United States
+1 (919) 000-0000
Biomason Timeline
Biomason Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | Upcoming | Generating Revenue | ||||
| 11. Later Stage VC (Series C) | 28-Feb-2022 | 0000 | 000.00 | Completed | Generating Revenue | |
| 10. Debt - PPP | 09-Apr-2020 | 000.00 | Completed | Generating Revenue | ||
| 9. Later Stage VC | 09-Dec-2019 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 8. Debt - General | 04-Mar-2016 | 00000 | 00.000 | Completed | Startup | |
| 7. Early Stage VC | 22-Dec-2015 | 00.00 | 00.000 | Completed | Startup | |
| 6. Grant | 01-Sep-2015 | 00000 | 00000 | Completed | Startup | |
| 5. Debt - General | 13-May-2014 | 00000 | 00000 | Completed | Startup | |
| 4. Grant | 01-Jan-2014 | $150K | $570K | Completed | Startup | |
| 3. Grant | 16-Sep-2013 | $664K | $570K | Completed | Startup |
Biomason Patents
Biomason Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020221335-A1 | Biological sintering without heat or pressure | Pending | 15-Feb-2019 | 0000000000 | |
| CA-3130264-A1 | Biological sintering without heat or pressure | Pending | 15-Feb-2019 | 00000000 | |
| US-20200262711-A1 | Biological sintering without heat or pressure | Pending | 15-Feb-2019 | 00000000 | |
| AU-2018346776-B2 | Biocementation method and system | Active | 05-Oct-2017 | 00000000 | 0 |
| EP-3692009-A1 | Biocementation method and system | Pending | 05-Oct-2017 | C01F11/06 |
Biomason Executive Team (6)
Biomason Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Anders Spohr Ph.D | Novo Holdings | Board Member | 000 0000 |
| Brad Knight | Self | Board Member | 000 0000 |
| Daniel Grant | Self | Board Member | 000 0000 |
| Ginger Dosier | Biomason | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 |
| Michael Noël | Self | Board Member | 000 0000 |
Biomason Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBiomason Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 2150 | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Celesta Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Hartree Partners | Asset Manager | Minority | 000 0000 | 000000 0 | |
| Martin Marietta | Corporation | Minority | 000 0000 | 000000 0 | |
| Novo Holdings | Venture Capital | Minority | 000 0000 | 000000 0 |